Martin Shkreli, the pharmaceutical entrepreneur facing U.S. charges of securities fraud, has said he had been the target of legal authorities for his much-criticized drug-price hikes and his over-the-top public persona, the Wall Street Journal reported.
Source:CBC | Business News http://ift.tt/1OGcFOP
0 commentaires:
Enregistrer un commentaire